{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:40:38Z","timestamp":1782513638641,"version":"3.54.5"},"reference-count":29,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.jns.2012.02.033","type":"journal-article","created":{"date-parts":[[2012,3,28]],"date-time":"2012-03-28T05:29:04Z","timestamp":1332912544000},"page":"47-51","source":"Crossref","is-referenced-by-count":42,"title":["Oral contraceptive use and clinical outcomes in patients with multiple sclerosis"],"prefix":"10.1016","volume":"317","author":[{"given":"Armando","family":"Sena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9my","family":"Couderc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana C.","family":"Vasconcelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Ferret-Sena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Pedrosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2012.02.033_bb0005","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.46.4.907","article-title":"Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Trials of New Agents in Multiple Sclerosis","volume":"46","author":"Lublin","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2012.02.033_bb0010","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1468-1331.2009.02850.x","article-title":"Sex ratio of multiple sclerosis and clinical phenotype","volume":"17","author":"Ramagopalan","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jns.2012.02.033_bb0015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jns.2009.04.014","article-title":"Sex hormones, brain damage and clinical course of multiple sclerosis","volume":"286","author":"Tomassini","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2012.02.033_bb0020","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/1352458508099479","article-title":"Gender-related differences in MS: a study of conventional and nonconventional MRI measures","volume":"15","author":"Antulov","year":"2009","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2012.02.033_bb0025","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jns.2009.05.028","article-title":"Estrogen treatment in multiple sclerosis","volume":"286","author":"Gold","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2012.02.033_bb0030","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1001\/archneur.62.9.1362","article-title":"Recent use of oral contraceptives and the risk of multiple sclerosis","volume":"62","author":"Alonso","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2012.02.033_bb0035","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1016\/j.fertnstert.2010.06.045","article-title":"Age at onset of multiple sclerosis is correlated to use of combined oral contraceptives and childbirth before diagnosis","volume":"94","author":"Holmqvist","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jns.2012.02.033_bb0040","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1600-0404.1979.tb02917.x","article-title":"Pregnancy, oral contraceptives and multiple sclerosis","volume":"59","author":"Poser","year":"1979","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jns.2012.02.033_bb0045","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.maturitas.2005.10.003","article-title":"Symptoms of multiple sclerosis in women in relation to sex steroid exposure","volume":"54","author":"Holmqvist","year":"2006","journal-title":"Maturitas"},{"key":"10.1016\/j.jns.2012.02.033_bb0050","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1093\/brain\/awp228","article-title":"A type I interferon signature in monocytes is associated with poor response to interferon-\u03b2 in multiple sclerosis","volume":"132","author":"Comabella","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.jns.2012.02.033_bb0055","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 Revisions to the \u00abMc Donald Criteria\u00bb","volume":"58","author":"Polman","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2012.02.033_bb0060","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2012.02.033_bb0065","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1212\/01.WNL.0000156155.19270.F8","article-title":"Multiple sclerosis severity score. Using disability and disease duration to rate disease severity","volume":"64","author":"Roxburgh","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2012.02.033_bb0070","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1177\/1352458510364633","article-title":"Analysis of multiple candidate genes in association with phenotypes of multiple sclerosis","volume":"16","author":"Sombekke","year":"2010","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2012.02.033_bb0075","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1212\/01.wnl.0000277658.78381.db","article-title":"Cigarette smoking and progression in multiple sclerosis","volume":"69","author":"Koch","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2012.02.033_bb0080","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/j.1468-1331.2009.02603.x","article-title":"Apolipoprotein E polymorphism interacts with cigarette smoking in progression of multiple sclerosis","volume":"16","author":"Sena","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jns.2012.02.033_bb0085","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/jnnp.2008.163816","article-title":"Long-term effects of childbirth in MS","volume":"81","author":"D'hooghe","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2012.02.033_bb0090","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0025-6196(11)63371-5","article-title":"Pregnancy and multiple sclerosis","volume":"72","author":"Damek","year":"1997","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jns.2012.02.033_bb0095","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/brain\/awh152","article-title":"Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse","volume":"127","author":"Vukusic","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.jns.2012.02.033_bb0100","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1093\/brain\/awq118","article-title":"The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability","volume":"133","author":"Scalfari","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jns.2012.02.033_bb0105","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev.neuro.30.051606.094313","article-title":"Multiple sclerosis: an immune or neurodegenerative disorder?","volume":"31","author":"Trapp","year":"2008","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.jns.2012.02.033_bb0110","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pharmthera.2010.01.006","article-title":"Neuroprotection in multiple sclerosis: a therapeutic challenge for the next decade","volume":"126","author":"Van der Walt","year":"2010","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jns.2012.02.033_bb0115","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/brain\/awq237","article-title":"Oestrogen receptor\u03b2 ligand: a novel treatment to enhance endogenous functional remyelination","volume":"133","author":"Crawford","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jns.2012.02.033_bb0120","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.4049\/jimmunol.170.3.1548","article-title":"Oral feeding with ethinyl estradiol suppresses and treats experimental autoimmune encephalomyelitis in SJL mice and inhibits the recruitment of inflammatory cells into the central nervous system","volume":"170","author":"Subramanian","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.jns.2012.02.033_bb0125","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2172-11-20","article-title":"GPR30, but not estrogen receptor-\u03b1, is crucial in the treatment of experimental autoimmune encephalomyelitis by oral ethinyl estradiol","volume":"11","author":"Yates","year":"2010","journal-title":"BMC Immunol"},{"key":"10.1016\/j.jns.2012.02.033_bb0130","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jneuroim.2010.01.013","article-title":"Progesterone treatment reduces disease severity and increases IL-10 in experimental autoimmune encephalomyelitis","volume":"220","author":"Yates","year":"2010","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2012.02.033_bb0135","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.4049\/jimmunol.0901351","article-title":"(Estrogen controls vitamin D3-mediated resitence to experimental autoimmune encephalomyelitis by controlling vitamin D3 metabolism and receptor expression","volume":"183","author":"Nashold","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jns.2012.02.033_bb0140","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jns.2011.06.035","article-title":"Vitamin D: evidence for its role as a prognosis factor in multiple sclerosis","volume":"311","author":"Mowry","year":"2011","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2012.02.033_bb0145","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/jnnp.2010.227942","article-title":"Vitamin D metabolites are associated with clinical and MRI outcomes in multiple sclerosis patients","volume":"82","author":"Weinstock-Guttman","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X12001177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X12001177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,24]],"date-time":"2018-11-24T21:54:34Z","timestamp":1543096474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X12001177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":29,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0022510X12001177"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2012.02.033","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}